Logo

Merck Presents Updated Results for Bifunctional Immunotherapy ...

DARMSTADT, Germany, October 22, 2018 /PRNewswire-AsiaNet/ -- The information contained is not intended for distribution in the USA, Canada or the UK ESMO Abstract #M7824 (TGF β-trap/anti-PD-L1): 10480, 1463P, 757P, 643P, 642P, 661P, 1931P- New data presented at the ESMO 2018 Congress include ...

Read more https://view-release/?pr-id=75866

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660